Investment
Features
FeesSafety
Academy
More
Pluang+

Compare 8x8 Inc (EGHT) vs Tilray Brands Inc (TLRY) Price & Performance

8x8 IncTrade
Tilray Brands IncTrade

Price performance (Past 24H)

Key statistics

8x8 Inc vs Tilray Brands Inc — how do they compare? 8x8 Inc trades at $1.92 (market cap $279.31M), while Tilray Brands Inc trades at $4.38 (market cap $541.36M). The key difference: Tilray Brands Inc is the larger of the two by market cap, and 8x8 Inc is trading nearer its 52-week high, Tilray Brands Inc nearer its low. Which is the better fit depends on your goals.

EGHTTLRY
Market Cap
$279.31M$541.36M
Sector
TechnologyHealth
52-Week High
$2.76$21.00
52-Week Low
$1.59$4.31
Enterprise Value
$556.99M$638.50M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

8x8 Inc

EGHT (8x8, Inc.) trades at $1.89, down 12.9% over 24 hours, with a bullish technical signal from moving averages but overbought RSI readings. The company reported a net loss of $27.21M in 2025 despite revenue of $715.07M, though recent quarters have beaten EPS estimates. Positive news includes AI product launches and industry awards, while analyst consensus is mixed with 39% buy ratings.

Outlook hinges on profitability improvement; projected net income of $2M in 2026 offers potential upside, but high debt and thin margins pose risks. Stock sentiment is cautiously optimistic due to innovation, yet volatility and competitive pressures require monitoring for sustained growth.

Tilray Brands Inc

TLRY trades at $4.355, down 0.57% on the day, amid a bearish technical signal and weak earnings performance. The company reported a net loss of $2.19 billion in 2025, with a negative net income margin of -156.67%, while revenue grew to $821.31 million. Recent news includes medical cannabis expansion in Panama and the acquisition of HelloMD to enhance digital healthcare capabilities.

The outlook remains challenging due to persistent losses and high debt levels, though low valuation ratios like P/S of 0.55 and P/B of 0.35 may attract value investors. Key risks include profitability struggles, regulatory uncertainty, and competitive pressures in the cannabis sector. Analyst sentiment is mixed, with 65% hold ratings reflecting caution.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About 8x8 Inc

8x8 is a provider of integrated cloud communications and contact center solutions. Its platform combines voice, video, chat, and contact center functionality into a single application to help businesses collaborate.

Read more on EGHT

About Tilray Brands Inc

Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.

Read more on TLRY